ストックスクリーナーアプリを入手
1.12
2.61%
-0.03
アフターアワーズ：
1.10
-0.02
-1.79%
Sonoma Pharmaceuticals Inc (SNOA) 最新ニュース
Reviva Pharmaceuticals Holdings (OTCPK:RVPH)Stock Analysis - Simply Wall Street
Sonoma Pharmaceuticals Adopts New Tax-Protection Rights Plan - The Globe and Mail
Kazia Therapeutics Limited (KZIA) stock price, news, quote and history - Yahoo Finance Singapore
Williams-Sonoma CFO Jeffrey Howie Sells 3,045 Shares - Yahoo Finance
Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Resistance at $1.32SuperTrend - siam.in
Williams-Sonoma, Inc. declares quarterly cash dividend - Yahoo Finance
Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Resistance at $1.32Stock Surge Alerts - dars.gov.et
Sonoma Pharmaceuticals (SNOA) Ticks Up to $1.31, Holding Above Key SupportHagopian Line - siam.in
Sonoma Pharmaceuticals (SNOA) Ticks Up to $1.31, Holding Above Key SupportBollinger Squeeze - careplusvn.com
Sonoma Pharmaceuticals (SNOA) Ticks Up to $1.31, Holding Above Key SupportNHNL Ratio - dars.gov.et
Sonoma Pharmaceuticals Stock Price Forecast. Should You Buy SNOA? - StockInvest.us
Sonoma (SNOA) Market: Holds Near $1.34 in the Available Record; Current Setup: the Session Ends Within the Reported Technical Boundaries on the DayIV Contraction - vinanet.vn
Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayMid Cap Momentum - vinanet.vn
Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayPut Dominated - vinanet.vn
Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayOverbought Signal Alerts - siam.in
Sonoma (SNOA) Shares: Holds Near $1.34 at the Close; Technical View: the Session Ends Within the Reported Technical Boundaries in Latest TradingBear Flag - vinanet.vn
Sonoma (SNOA) Shares: Holds Near $1.34 at the Close; Technical View: the Session Ends Within the Reported Technical Boundaries in Latest TradingPrice Surge Stocks - siam.in
Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com Nigeria
Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals Cancels Adjourned Special Stockholder Meeting - TipRanks
Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com Canada
Sonoma Pharmaceuticals cancels special meeting due to lack of quorum - Investing.com
Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com UK
Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com Canada
Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com India
Price to earnings forward of Sonoma Pharmaceuticals, Inc. – SWB:O8Z - TradingView
WEBTOON (WBTN) Earnings Brief: EPS Clears the Reported Estimate in the Latest Session; Trading Response: Shares Finish 1.90% Down on the DayEarnings Decline Risk - www.dars.gov.et
Pagaya Technologies Warrants (PGYWW) Drop 7.02% to $0.03 as Trading Remains Pinned at Penny LevelETF Outflow Streak - dars.gov.et
Sonoma Pharmaceuticals reports 60% revenue growth in Q1 By Investing.com - Investing.com Nigeria
Sonoma Pharmaceuticals reports 60% revenue growth in Q1 - Investing.com
Sonoma FY2027 Q1 earnings: 60% revenue growth moves EBITDA positive - TradingKey
Sonoma Pharmaceuticals reports 60% revenue growth in Q1 By Investing.com - Investing.com Canada
Sonoma Pharmaceuticals Q1 revenue rises on US growth - TradingView
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Bay to Bay News
BRIEF-Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million - TradingView
Sonoma U.S. Revenue Climbs 141%; First-Ever Positive Adjusted EBITDA - Stock Titan
Sonoma Pharmaceuticals, Inc. Q1 2027: Revenue $6.41M, EPS $(0.09) — 10-Q Summary - TradingView
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue - TradingView
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - ACCESS Newswire
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Yahoo Finance
Sonoma Pharmaceuticals (SNOA) Slides 5.83% to $1.13 as Key Support Level LoomsStop Loss Guidance - dars.gov.et
SNOA Q1'26 Earnings: EPS estimate is (0.30) USD - TradingView
Sonoma Pharmaceuticals (SNOA) Slides 5.83% to $1.13 as Key Support Level LoomsBreak of Structure - vinanet.vn
SNOA Q2 2026 Earnings: Narrow EPS Miss Weighs on SharesROE Trend Analysis - vinanet.vn
SNOA Q2 2026 Earnings: Narrow EPS Miss Weighs on SharesEarnings Revision Upgrade - dars.gov.et
Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July By Investing.com - Investing.com Nigeria
Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals (SNOA) Hovers Near Support as Slight Decline ContinuesEarnings Miss Risk - dars.gov.et
Sonoma Pharmaceuticals (SNOA) Hovers Near Support as Slight Decline ContinuesRVOL Breakout - vinanet.vn
Sonoma Pharmaceuticals Inc (SNOA) Institutional Confidence - TradingKey
3.58%
7.97%
大文字化:
|
ボリューム (24 時間):